The recent arrival of this new formulation represents a possibly significant advancement in the handling of type 2 the illness. This therapy builds upon the existing success of lower amounts, showing encouraging results in reducing blood glycemic control and supporting a decrease in weight. Clinicians are exploring its full impact on heart outcomes